You are here » Home » Companies » Company Overview » Godavari Drugs Ltd

Godavari Drugs Ltd.

BSE: 530317 Sector: Health care
NSE: N.A. ISIN Code: INE362C01012
BSE LIVE 15:18 | 12 Dec 35.95 0.85
(2.42%)
OPEN

34.60

HIGH

36.00

LOW

34.45

NSE 05:30 | 01 Jan Stock Is Not Traded.
OPEN 34.60
PREVIOUS CLOSE 35.10
VOLUME 3781
52-Week high 50.00
52-Week low 30.00
P/E 23.97
Mkt Cap.(Rs cr) 27
Buy Price 35.00
Buy Qty 180.00
Sell Price 35.95
Sell Qty 18.00
OPEN 34.60
CLOSE 35.10
VOLUME 3781
52-Week high 50.00
52-Week low 30.00
P/E 23.97
Mkt Cap.(Rs cr) 27
Buy Price 35.00
Buy Qty 180.00
Sell Price 35.95
Sell Qty 18.00

Godavari Drugs Ltd. (GODAVARIDRUGS) - Company History

Godavari Drugs is engaged in manufacturing drugs. Sulphamethoxazole (SMX), the main product of the company, is a widely used anti-bacterial drug enjoying good export demand. The company has expanded its SMX capacity from 540 tpa to 720 tpa, integrating backward into the manufacture of drug intermediates, sulphamethoxide (cap.: 450 tpa) and diethyl oxalate, DEO (cap.: 750 tpa), and diversifying into the manufacture of trimetroprim, TMP (cap.: 144 tpa). The diversification into TMP is beneficial as SMX and TMP are used in combination to treat a wide variety of infections. The backward integration into SMO and DEO will enhance value-addition. In fact, Siris and Chemox Chemicals, both having good capacities of SMX, have recently gone in for the production of SMO. In 2000 the company introduced 'Pyrazyamide' in the market. Since the product is being well accepted in the market the company is planning to increase the capacity of 'Pyrazyamide' of 180 TPA and have also finalised on other products Cislactum,which is a intermediate used to produce Diltiazem an anti anginal drug.